Showing results (2591-2600 of 3,768) with videos related to
Sort By:
Pageof 377
Nanomaterials (Basel, Switzerland)|February 9, 2020
Investigation of the Electrical Properties of Microtubule Ensembles under Cell-Like ConditionsAarat P Kalra, Sahil D Patel, Asadullah F Bhuiyan, et al.Physiological Reports|November 12, 2021
Utility of the oxygen pulse in the diagnosis of obstructive coronary artery disease in physically fit patientsBradley J Petek, Timothy W Churchill, J Sawalla Guseh, et al.Biochemistry|January 12, 1988
Growth hormone promoted tyrosyl phosphorylation of growth hormone receptors in murine 3T3-F442A fibroblasts and adipocytesC M Foster, J A Shafer, F W Rozsa, et al.Journal of the American Heart Association|August 29, 2025
Cardiopulmonary Exercise Testing for Characterization of Hypertrophic Cardiomyopathy: A Meta-AnalysisIsabela Landsteiner, Ahmad Masri, Sara Saberi, et al.Anticancer Research|July 20, 2021
The Use of Crowdfunding to Support Radiation Therapy Cancer TreatmentsArpan V Prabhu, Milan Bimali, Mihailo Miljanic, et al.JAMA Oncology|August 4, 2018
Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600-Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical TrialsAxel Hauschild, James Larkin, Antoni Ribas, et al.Breast Cancer Research and Treatment|May 12, 2017
Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasisGail D Lewis Phillips, Merry C Nishimura, Jennifer Arca Lacap, et al.Obesity (Silver Spring, Md.)|June 30, 2018
CD4+ and CD8+ T-Cell-Specific DNA Cytosine Methylation Differences Associated With ObesityNatalie M Hohos, Alicia K Smith, Varun Kilaru, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neuF H Valone, P A Kaufman, P M Guyre, et al.Oncotarget|October 21, 2016
Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinomaAnne Lynn S Chang, Karl D Lewis, Sarah T Arron, et al.Pageof 377